cancer therapy

The HER2CLIMB-02 trial reveals significant benefits, especially for breast cancer patients with brain metastases

Colorectal cancer is the second-leading cause of cancer mortality with 52,550 deaths per year

Identifying peptide backbones that link protein complexes to cancer cells can help maximize CAR therapy applicability to different tumor types

CLL makes up a quarter of leukemia cases among adults and NHL accounts for 4 percent of all cancers in the US

Tibsovo can be used with FDA-approved companion diagnostic RealTime IDH1 Assay to detect and treat MDS

Single-agent immunotherapy shrinks over half of advanced melanomas when given before surgery

Some 70–90 percent of patients with hepatocellular carcinoma experience cancer recurrence after curative treatment

Results showed a 32 percent lower chance of cancer recurrence, progression, or death with immunotherapy plus chemotherapy versus chemotherapy alone